By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
DenyAccept
October 12, 2023

Sky News: AI-driven technology could transform aneurysm treatment

PreSize has so far been used in operations involving 375 patients, including in seven hospitals in England and Scotland, and some in Germany, Finland and Ukraine.
Words by
Photography
Posted
October 12, 2023
Share ON SOCIAL

Note to editors

Related articles

November 15, 2024

CEO Dr Katerina Spranger Receives Purple Plaque Honour from Innovate UK

Dr Katerina Spranger has been honoured with a Purple Plaque in recognition of winning the prestigious Innovate UK Women in Innovation Award
September 12, 2024

Recruitment Complete for Landmark Clinical Impact Trial of PreSize® Neurovascular

The clinical trial collecting evidence on the impact of PreSize® Neurovascular has successfully recruited all 100 patients…
Technology
Company
Insights
Privacy Policy
Terms & Conditions
©2024 Oxford Heartbeat®. All rights reserved.
Shaping the surgery of tomorrow
Shaping the surgery of tomorrow